Ankara Üniversitesi, Cumhuriyet tarihini ve misyonunu milletiyle özdeşleştirmiş, bütünleştirmiş bir üniversitedir.

During the past decade, Ankara University conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 3 clinical trials were completed, i.e. on average, 10.7% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 3 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ankara University" #1 sponsor was "Ankara University" with 16 trials, followed by "European Myeloma Network" with 3 trials sponsored, "Eiger BioPharmaceuticals" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Abdi Ibrahim Ilac San. ve Tic A.S." with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ankara University" #1 collaborator was "Ankara University" with 2 trials as a collaborator, "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Janssen Pharmaceutica" with 1 trials as a collaborator and "Janssen Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Ankara University" are "Multiple Myeloma" (3 trials), "COVID-19" (2 trials), "Chronic Hepatitis D Infection" (2 trials), "Pain" (2 trials) and "All the Pediatric Patients Needed Intubation for Surgery" (1 trials). Many other conditions were trialed in "Ankara University" in a lesser frequency.

Most popular intervention types in "Ankara University" are "Drug" (12 trials), "Other" (8 trials), "Device" (4 trials), "Behavioral" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Daratumumab" (2 trials), "Lenalidomide" (2 trials), "Placebo" (2 trials), "lonafarnib" (2 trials) and "ritonavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ankara University" are 36 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ankara University". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 19 completed trials in Ankara University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ankara University, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".

Ankara University has several departments that took part in Clinical trials: "Ankara University Medical Faculty Cebeci Hospital" - 14 trials, "Ankara University Faculty of Dentistry" - 10 trials, "Ankara University Medical Faculty" - 93 trials, "Ankara University Medical Faculty; Medikal Onkoloji" - 5 trials, "Ankara University Faculty of Medicine, Department of Obstetrics and Gynecology" - 4 trials, "Ankara University Medical Faculty, Ibni-Sina Hospital" - 4 trials, "Ankara University Medical School Anesthesiology and ICU Department" - 3 trials, "Zekai Tahir Burak Maternity Teaching Hospital, Division of Neonatology" - 6 trials, "Gulhane School of Medicine Dep. of Endocrine and Metabolism" - 2 trials, "Ankara University, Pediatric Surgery" - 2 trials, "Ankara University Faculty of Nursing" - 2 trials, "Ankara University Faculty of Medicine, Ibni Sina Hospital colonoscopy lab" - 2 trials, "Ankara Üniversitesi Gastroenteroloji Bilim Dalı Cebeci" - 2 trials